TrimRx's Blog
Semaglutide Alcohol Use Disorder — New Evidence 2026
Semaglutide shows potential in reducing alcohol cravings through GLP-1 receptor mechanisms. Research data, clinical evidence, and what patients should
Tirzepatide Hair Loss — Causes, Timeline & What to Expect
Tirzepatide hair loss affects 5–8% of patients, typically 3–5 months after starting treatment due to telogen effluvium. Here’s what reverses it.
Tirzepatide Calorie Intake — What You Actually Need to Eat
Tirzepatide doesn’t require extreme calorie restriction — most patients lose weight eating 1,200–1,800 calories daily while maintaining muscle mass and
Tirzepatide Intermittent Fasting — Protocol Timing Guide
Tirzepatide intermittent fasting works best with 16:8 protocols — the medication’s 5-day half-life maintains appetite suppression through fasting windows
Semaglutide Social Anxiety — Does It Cause or Reduce It?
Semaglutide can worsen social anxiety in 15–20% of patients through nausea-triggered isolation, though symptom management and metabolic improvements often
Stopped Losing Weight on Tirzepatide? Here’s Why | TrimRx
Plateaus on tirzepatide happen to 40–60% of patients after 12–16 weeks. We break down the biological mechanisms causing stalls and what actually works to
Tirzepatide Plateau 3 Months — Why Weight Loss Stalls
Tirzepatide plateau at 3 months happens when adaptive thermogenesis kicks in. Here’s how metabolic adaptation works and what adjustments restart progress.
Semaglutide Microdosing Safety — Risks & Best Practices
Semaglutide microdosing carries risks most guides ignore: receptor desensitisation, dose inconsistency, and loss of therapeutic efficacy. Here’s what
Semaglutide Microdosing Protocol — How It Works
Semaglutide microdosing starts at 0.25–0.5mg weekly, titrating slowly to minimize side effects while achieving sustained weight loss through optimized
